Early Phase 1 SCLC Clinical Trials

4 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–4 of 4 trials

Recruiting

Early Phase 1

Safety and Efficacy of NK510 to Treat NSCLC

NSCLC

Base Therapeutics (Shanghai) Co., Ltd.12 enrolled1 locationNCT06097962

Recruiting

Early Phase 1

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

NSCLCAdvanced/Metastatic Solid Tumors

Shanghai Henlius Biotech254 enrolled2 locationsNCT07274813

Recruiting

Early Phase 1

Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer

NSCLC (Advanced Non-small Cell Lung Cancer)HCC - Hepatocellular Carcinoma

Wondercel Biotech (ShenZhen)60 enrolled2 locationsNCT06653023

Recruiting

Early Phase 1

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Small Cell Lung Cancer ( SCLC )CAR-T Cell Therapy

TCRCure Biopharma Ltd.24 enrolled1 locationNCT07246304